hepatitis C

HCV patients at risk of nonadherence using Proteus' digital pill achieve sustained viral clearance
By Dave Muoio | 05:09 pm | November 14, 2019
The multi-center, single-arm, open-label study recorded an overall medication adherence rate of 93% alongside strong treatment outcomes.
PharMedQuest invests in helparound, will co-market HIV, Hepatitis C management platform
By Laura Lovett | 03:55 pm | December 20, 2017